Podoplanin immunoexpression in odontogenic lesions: a systematic review, meta-analysis, and integrated bioinformatic analysis

Background Podoplanin (PDPN) is a transmembrane glycoprotein implicated in the pathogenesis of odontogenic lesions (OL). It is localized at the membrane and cytoplasmic level, and its interaction with other proteins could trigger cell proliferation, invasion and migration. The main objective of this...

Full description

Saved in:
Bibliographic Details
Published inDiagnostic pathology Vol. 19; no. 1; pp. 115 - 22
Main Authors Alarcón-Sánchez, Mario Alberto, Luna-Bonilla, Getsemani, Romero-Servin, Selenne, Heboyan, Artak
Format Journal Article
LanguageEnglish
Published London BioMed Central 24.08.2024
BioMed Central Ltd
BMC
Subjects
Online AccessGet full text
ISSN1746-1596
1746-1596
DOI10.1186/s13000-024-01540-y

Cover

Abstract Background Podoplanin (PDPN) is a transmembrane glycoprotein implicated in the pathogenesis of odontogenic lesions (OL). It is localized at the membrane and cytoplasmic level, and its interaction with other proteins could trigger cell proliferation, invasion and migration. The main objective of this systematic review is to explore the immunoexpression pattern of podoplanin in OL. In addition, as secondary objectives, we aimed to compare the immunostaining intensity of PDPN in OL, to analyze its interaction networks by bioinformatic analysis and to highlight its importance as a potential diagnostic marker useful in the pathogenesis of OL. Methods The protocol was developed following PRISMA and Cochrane guidelines. The digital search was performed in the databases: PubMed/MEDLINE, ScienceDirect, Scopus, Web of Science and Google Schoolar from August 15, 2010 to June 15, 2023. We included cross-sectional and cohort studies that will analyze the pattern of PDPN immunoexpression in OL. Two investigators independently searched for eligible articles, selected titles and abstracts, analyzed full text, conducted data collection, and performed assessment of study quality and risk of bias. In addition, part of the results were summarized through a random-effects meta-analysis. STRING database was used for protein-protein interaction analysis. Results Twenty-nine relevant studies were included. The ages of the subjects ranged from 2 to 89 years, with a mean age of 33.41 years. Twenty-two point two percent were female, 21.4% were male, and in 56.4% the gender of the participants was not specified. A total of 1,337 OL samples were analyzed for PDPN immunoexpression pattern. Ninety-four (7.03%) were dental follicles and germs, 715 (53.47%) were odontogenic cysts, and 528 (39.49%) were odontogenic tumors. Meta-analysis indicated that the immunostaining intensity was significantly stronger in odontogenic keratocysts compared to dentigerous cysts (SMD=3.3(CI=1.85-4.82, p =0.000*). Furthermore, bioinformatic analysis revealed that PECAM-1, TNFRF10B, MSN, EZR and RDX interact directly with PDPN and their expression in OL was demonstrated. Conclusions The results of the present systematic review support the unique immunoexpression of PDPN as a potential useful diagnostic marker in the pathogenesis of OL.
AbstractList Podoplanin (PDPN) is a transmembrane glycoprotein implicated in the pathogenesis of odontogenic lesions (OL). It is localized at the membrane and cytoplasmic level, and its interaction with other proteins could trigger cell proliferation, invasion and migration. The main objective of this systematic review is to explore the immunoexpression pattern of podoplanin in OL. In addition, as secondary objectives, we aimed to compare the immunostaining intensity of PDPN in OL, to analyze its interaction networks by bioinformatic analysis and to highlight its importance as a potential diagnostic marker useful in the pathogenesis of OL. The protocol was developed following PRISMA and Cochrane guidelines. The digital search was performed in the databases: PubMed/MEDLINE, ScienceDirect, Scopus, Web of Science and Google Schoolar from August 15, 2010 to June 15, 2023. We included cross-sectional and cohort studies that will analyze the pattern of PDPN immunoexpression in OL. Two investigators independently searched for eligible articles, selected titles and abstracts, analyzed full text, conducted data collection, and performed assessment of study quality and risk of bias. In addition, part of the results were summarized through a random-effects meta-analysis. STRING database was used for protein-protein interaction analysis. Twenty-nine relevant studies were included. The ages of the subjects ranged from 2 to 89 years, with a mean age of 33.41 years. Twenty-two point two percent were female, 21.4% were male, and in 56.4% the gender of the participants was not specified. A total of 1,337 OL samples were analyzed for PDPN immunoexpression pattern. Ninety-four (7.03%) were dental follicles and germs, 715 (53.47%) were odontogenic cysts, and 528 (39.49%) were odontogenic tumors. Meta-analysis indicated that the immunostaining intensity was significantly stronger in odontogenic keratocysts compared to dentigerous cysts (SMD=3.3(CI=1.85-4.82, p=0.000*). Furthermore, bioinformatic analysis revealed that PECAM-1, TNFRF10B, MSN, EZR and RDX interact directly with PDPN and their expression in OL was demonstrated. The results of the present systematic review support the unique immunoexpression of PDPN as a potential useful diagnostic marker in the pathogenesis of OL.
Abstract Background Podoplanin (PDPN) is a transmembrane glycoprotein implicated in the pathogenesis of odontogenic lesions (OL). It is localized at the membrane and cytoplasmic level, and its interaction with other proteins could trigger cell proliferation, invasion and migration. The main objective of this systematic review is to explore the immunoexpression pattern of podoplanin in OL. In addition, as secondary objectives, we aimed to compare the immunostaining intensity of PDPN in OL, to analyze its interaction networks by bioinformatic analysis and to highlight its importance as a potential diagnostic marker useful in the pathogenesis of OL. Methods The protocol was developed following PRISMA and Cochrane guidelines. The digital search was performed in the databases: PubMed/MEDLINE, ScienceDirect, Scopus, Web of Science and Google Schoolar from August 15, 2010 to June 15, 2023. We included cross-sectional and cohort studies that will analyze the pattern of PDPN immunoexpression in OL. Two investigators independently searched for eligible articles, selected titles and abstracts, analyzed full text, conducted data collection, and performed assessment of study quality and risk of bias. In addition, part of the results were summarized through a random-effects meta-analysis. STRING database was used for protein-protein interaction analysis. Results Twenty-nine relevant studies were included. The ages of the subjects ranged from 2 to 89 years, with a mean age of 33.41 years. Twenty-two point two percent were female, 21.4% were male, and in 56.4% the gender of the participants was not specified. A total of 1,337 OL samples were analyzed for PDPN immunoexpression pattern. Ninety-four (7.03%) were dental follicles and germs, 715 (53.47%) were odontogenic cysts, and 528 (39.49%) were odontogenic tumors. Meta-analysis indicated that the immunostaining intensity was significantly stronger in odontogenic keratocysts compared to dentigerous cysts (SMD=3.3(CI=1.85-4.82, p=0.000*). Furthermore, bioinformatic analysis revealed that PECAM-1, TNFRF10B, MSN, EZR and RDX interact directly with PDPN and their expression in OL was demonstrated. Conclusions The results of the present systematic review support the unique immunoexpression of PDPN as a potential useful diagnostic marker in the pathogenesis of OL.
BackgroundPodoplanin (PDPN) is a transmembrane glycoprotein implicated in the pathogenesis of odontogenic lesions (OL). It is localized at the membrane and cytoplasmic level, and its interaction with other proteins could trigger cell proliferation, invasion and migration. The main objective of this systematic review is to explore the immunoexpression pattern of podoplanin in OL. In addition, as secondary objectives, we aimed to compare the immunostaining intensity of PDPN in OL, to analyze its interaction networks by bioinformatic analysis and to highlight its importance as a potential diagnostic marker useful in the pathogenesis of OL.MethodsThe protocol was developed following PRISMA and Cochrane guidelines. The digital search was performed in the databases: PubMed/MEDLINE, ScienceDirect, Scopus, Web of Science and Google Schoolar from August 15, 2010 to June 15, 2023. We included cross-sectional and cohort studies that will analyze the pattern of PDPN immunoexpression in OL. Two investigators independently searched for eligible articles, selected titles and abstracts, analyzed full text, conducted data collection, and performed assessment of study quality and risk of bias. In addition, part of the results were summarized through a random-effects meta-analysis. STRING database was used for protein-protein interaction analysis.ResultsTwenty-nine relevant studies were included. The ages of the subjects ranged from 2 to 89 years, with a mean age of 33.41 years. Twenty-two point two percent were female, 21.4% were male, and in 56.4% the gender of the participants was not specified. A total of 1,337 OL samples were analyzed for PDPN immunoexpression pattern. Ninety-four (7.03%) were dental follicles and germs, 715 (53.47%) were odontogenic cysts, and 528 (39.49%) were odontogenic tumors. Meta-analysis indicated that the immunostaining intensity was significantly stronger in odontogenic keratocysts compared to dentigerous cysts (SMD=3.3(CI=1.85-4.82, p=0.000*). Furthermore, bioinformatic analysis revealed that PECAM-1, TNFRF10B, MSN, EZR and RDX interact directly with PDPN and their expression in OL was demonstrated.ConclusionsThe results of the present systematic review support the unique immunoexpression of PDPN as a potential useful diagnostic marker in the pathogenesis of OL.
Background Podoplanin (PDPN) is a transmembrane glycoprotein implicated in the pathogenesis of odontogenic lesions (OL). It is localized at the membrane and cytoplasmic level, and its interaction with other proteins could trigger cell proliferation, invasion and migration. The main objective of this systematic review is to explore the immunoexpression pattern of podoplanin in OL. In addition, as secondary objectives, we aimed to compare the immunostaining intensity of PDPN in OL, to analyze its interaction networks by bioinformatic analysis and to highlight its importance as a potential diagnostic marker useful in the pathogenesis of OL. Methods The protocol was developed following PRISMA and Cochrane guidelines. The digital search was performed in the databases: PubMed/MEDLINE, ScienceDirect, Scopus, Web of Science and Google Schoolar from August 15, 2010 to June 15, 2023. We included cross-sectional and cohort studies that will analyze the pattern of PDPN immunoexpression in OL. Two investigators independently searched for eligible articles, selected titles and abstracts, analyzed full text, conducted data collection, and performed assessment of study quality and risk of bias. In addition, part of the results were summarized through a random-effects meta-analysis. STRING database was used for protein-protein interaction analysis. Results Twenty-nine relevant studies were included. The ages of the subjects ranged from 2 to 89 years, with a mean age of 33.41 years. Twenty-two point two percent were female, 21.4% were male, and in 56.4% the gender of the participants was not specified. A total of 1,337 OL samples were analyzed for PDPN immunoexpression pattern. Ninety-four (7.03%) were dental follicles and germs, 715 (53.47%) were odontogenic cysts, and 528 (39.49%) were odontogenic tumors. Meta-analysis indicated that the immunostaining intensity was significantly stronger in odontogenic keratocysts compared to dentigerous cysts (SMD=3.3(CI=1.85-4.82, p =0.000*). Furthermore, bioinformatic analysis revealed that PECAM-1, TNFRF10B, MSN, EZR and RDX interact directly with PDPN and their expression in OL was demonstrated. Conclusions The results of the present systematic review support the unique immunoexpression of PDPN as a potential useful diagnostic marker in the pathogenesis of OL.
Podoplanin (PDPN) is a transmembrane glycoprotein implicated in the pathogenesis of odontogenic lesions (OL). It is localized at the membrane and cytoplasmic level, and its interaction with other proteins could trigger cell proliferation, invasion and migration. The main objective of this systematic review is to explore the immunoexpression pattern of podoplanin in OL. In addition, as secondary objectives, we aimed to compare the immunostaining intensity of PDPN in OL, to analyze its interaction networks by bioinformatic analysis and to highlight its importance as a potential diagnostic marker useful in the pathogenesis of OL. The protocol was developed following PRISMA and Cochrane guidelines. The digital search was performed in the databases: PubMed/MEDLINE, ScienceDirect, Scopus, Web of Science and Google Schoolar from August 15, 2010 to June 15, 2023. We included cross-sectional and cohort studies that will analyze the pattern of PDPN immunoexpression in OL. Two investigators independently searched for eligible articles, selected titles and abstracts, analyzed full text, conducted data collection, and performed assessment of study quality and risk of bias. In addition, part of the results were summarized through a random-effects meta-analysis. STRING database was used for protein-protein interaction analysis. Twenty-nine relevant studies were included. The ages of the subjects ranged from 2 to 89 years, with a mean age of 33.41 years. Twenty-two point two percent were female, 21.4% were male, and in 56.4% the gender of the participants was not specified. A total of 1,337 OL samples were analyzed for PDPN immunoexpression pattern. Ninety-four (7.03%) were dental follicles and germs, 715 (53.47%) were odontogenic cysts, and 528 (39.49%) were odontogenic tumors. Meta-analysis indicated that the immunostaining intensity was significantly stronger in odontogenic keratocysts compared to dentigerous cysts (SMD=3.3(CI=1.85-4.82, p=0.000*). Furthermore, bioinformatic analysis revealed that PECAM-1, TNFRF10B, MSN, EZR and RDX interact directly with PDPN and their expression in OL was demonstrated. The results of the present systematic review support the unique immunoexpression of PDPN as a potential useful diagnostic marker in the pathogenesis of OL.
Podoplanin (PDPN) is a transmembrane glycoprotein implicated in the pathogenesis of odontogenic lesions (OL). It is localized at the membrane and cytoplasmic level, and its interaction with other proteins could trigger cell proliferation, invasion and migration. The main objective of this systematic review is to explore the immunoexpression pattern of podoplanin in OL. In addition, as secondary objectives, we aimed to compare the immunostaining intensity of PDPN in OL, to analyze its interaction networks by bioinformatic analysis and to highlight its importance as a potential diagnostic marker useful in the pathogenesis of OL.BACKGROUNDPodoplanin (PDPN) is a transmembrane glycoprotein implicated in the pathogenesis of odontogenic lesions (OL). It is localized at the membrane and cytoplasmic level, and its interaction with other proteins could trigger cell proliferation, invasion and migration. The main objective of this systematic review is to explore the immunoexpression pattern of podoplanin in OL. In addition, as secondary objectives, we aimed to compare the immunostaining intensity of PDPN in OL, to analyze its interaction networks by bioinformatic analysis and to highlight its importance as a potential diagnostic marker useful in the pathogenesis of OL.The protocol was developed following PRISMA and Cochrane guidelines. The digital search was performed in the databases: PubMed/MEDLINE, ScienceDirect, Scopus, Web of Science and Google Schoolar from August 15, 2010 to June 15, 2023. We included cross-sectional and cohort studies that will analyze the pattern of PDPN immunoexpression in OL. Two investigators independently searched for eligible articles, selected titles and abstracts, analyzed full text, conducted data collection, and performed assessment of study quality and risk of bias. In addition, part of the results were summarized through a random-effects meta-analysis. STRING database was used for protein-protein interaction analysis.METHODSThe protocol was developed following PRISMA and Cochrane guidelines. The digital search was performed in the databases: PubMed/MEDLINE, ScienceDirect, Scopus, Web of Science and Google Schoolar from August 15, 2010 to June 15, 2023. We included cross-sectional and cohort studies that will analyze the pattern of PDPN immunoexpression in OL. Two investigators independently searched for eligible articles, selected titles and abstracts, analyzed full text, conducted data collection, and performed assessment of study quality and risk of bias. In addition, part of the results were summarized through a random-effects meta-analysis. STRING database was used for protein-protein interaction analysis.Twenty-nine relevant studies were included. The ages of the subjects ranged from 2 to 89 years, with a mean age of 33.41 years. Twenty-two point two percent were female, 21.4% were male, and in 56.4% the gender of the participants was not specified. A total of 1,337 OL samples were analyzed for PDPN immunoexpression pattern. Ninety-four (7.03%) were dental follicles and germs, 715 (53.47%) were odontogenic cysts, and 528 (39.49%) were odontogenic tumors. Meta-analysis indicated that the immunostaining intensity was significantly stronger in odontogenic keratocysts compared to dentigerous cysts (SMD=3.3(CI=1.85-4.82, p=0.000*). Furthermore, bioinformatic analysis revealed that PECAM-1, TNFRF10B, MSN, EZR and RDX interact directly with PDPN and their expression in OL was demonstrated.RESULTSTwenty-nine relevant studies were included. The ages of the subjects ranged from 2 to 89 years, with a mean age of 33.41 years. Twenty-two point two percent were female, 21.4% were male, and in 56.4% the gender of the participants was not specified. A total of 1,337 OL samples were analyzed for PDPN immunoexpression pattern. Ninety-four (7.03%) were dental follicles and germs, 715 (53.47%) were odontogenic cysts, and 528 (39.49%) were odontogenic tumors. Meta-analysis indicated that the immunostaining intensity was significantly stronger in odontogenic keratocysts compared to dentigerous cysts (SMD=3.3(CI=1.85-4.82, p=0.000*). Furthermore, bioinformatic analysis revealed that PECAM-1, TNFRF10B, MSN, EZR and RDX interact directly with PDPN and their expression in OL was demonstrated.The results of the present systematic review support the unique immunoexpression of PDPN as a potential useful diagnostic marker in the pathogenesis of OL.CONCLUSIONSThe results of the present systematic review support the unique immunoexpression of PDPN as a potential useful diagnostic marker in the pathogenesis of OL.
Background Podoplanin (PDPN) is a transmembrane glycoprotein implicated in the pathogenesis of odontogenic lesions (OL). It is localized at the membrane and cytoplasmic level, and its interaction with other proteins could trigger cell proliferation, invasion and migration. The main objective of this systematic review is to explore the immunoexpression pattern of podoplanin in OL. In addition, as secondary objectives, we aimed to compare the immunostaining intensity of PDPN in OL, to analyze its interaction networks by bioinformatic analysis and to highlight its importance as a potential diagnostic marker useful in the pathogenesis of OL. Methods The protocol was developed following PRISMA and Cochrane guidelines. The digital search was performed in the databases: PubMed/MEDLINE, ScienceDirect, Scopus, Web of Science and Google Schoolar from August 15, 2010 to June 15, 2023. We included cross-sectional and cohort studies that will analyze the pattern of PDPN immunoexpression in OL. Two investigators independently searched for eligible articles, selected titles and abstracts, analyzed full text, conducted data collection, and performed assessment of study quality and risk of bias. In addition, part of the results were summarized through a random-effects meta-analysis. STRING database was used for protein-protein interaction analysis. Results Twenty-nine relevant studies were included. The ages of the subjects ranged from 2 to 89 years, with a mean age of 33.41 years. Twenty-two point two percent were female, 21.4% were male, and in 56.4% the gender of the participants was not specified. A total of 1,337 OL samples were analyzed for PDPN immunoexpression pattern. Ninety-four (7.03%) were dental follicles and germs, 715 (53.47%) were odontogenic cysts, and 528 (39.49%) were odontogenic tumors. Meta-analysis indicated that the immunostaining intensity was significantly stronger in odontogenic keratocysts compared to dentigerous cysts (SMD=3.3(CI=1.85-4.82, p=0.000*). Furthermore, bioinformatic analysis revealed that PECAM-1, TNFRF10B, MSN, EZR and RDX interact directly with PDPN and their expression in OL was demonstrated. Conclusions The results of the present systematic review support the unique immunoexpression of PDPN as a potential useful diagnostic marker in the pathogenesis of OL. Keywords: PDPN Protein, Human, Odontogenic Tumors, Odontogenic Cysts, Systematic Review
ArticleNumber 115
Audience Academic
Author Heboyan, Artak
Alarcón-Sánchez, Mario Alberto
Luna-Bonilla, Getsemani
Romero-Servin, Selenne
Author_xml – sequence: 1
  givenname: Mario Alberto
  orcidid: 0000-0001-6727-7969
  surname: Alarcón-Sánchez
  fullname: Alarcón-Sánchez, Mario Alberto
  email: marioaasanchez@hotmail.com
  organization: Biomedical Science, Faculty of Chemical-Biological Sciences, Autonomous University of Guerrero
– sequence: 2
  givenname: Getsemani
  surname: Luna-Bonilla
  fullname: Luna-Bonilla, Getsemani
  organization: Biomedical Science, Faculty of Chemical-Biological Sciences, Autonomous University of Guerrero
– sequence: 3
  givenname: Selenne
  orcidid: 0000-0002-4992-0567
  surname: Romero-Servin
  fullname: Romero-Servin, Selenne
  organization: Oral and Maxillofacial Pathology, National School of Higher Studies, Leon Unit of the National Autonomous University of Mexico
– sequence: 4
  givenname: Artak
  orcidid: 0000-0001-8329-3205
  surname: Heboyan
  fullname: Heboyan, Artak
  email: heboyan.artak@gmail.com
  organization: Department of Research Analytics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Department of Prosthodontics, Faculty of Stomatology, Yerevan State Medical University after Mkhitar Heratsi, Department of Prosthodontics, School of Dentistry, Tehran University of Medical Sciences
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39182093$$D View this record in MEDLINE/PubMed
BookMark eNp9kktv1TAQhSNURB_wB1igSGxYNGUc5-GwqyoelSqBBHtrYk-uXCX2xc4t3AX_nblNL4UKVVkkOvnOGXtmjrMDHzxl2UsBZ0Ko5m0SEgAKKKsCRF1BsX2SHYm2agpRd83BX9-H2XFK1wBVXZfwLDuUnVAldPIo-_Ul2LAe0Tufu2na-EA_15FScoEFn_NfP4cVeWfykXZqepdjnrZppglnViPdOPpxmk80Y4Eex21y6TRHb9k_0yriTDbvXXB-CHHx7LHn2dMBx0Qv7t4n2dcP779dfCquPn-8vDi_KgwfeC4s2l6oHlqpmkZCXeNgsGvBqNqAtS1VgI2VBoW0_QCDkYJMW4HquE8kT7LLJdUGvNbr6CaMWx3Q6VshxJXGyMcaSQ-NUlTWJGTbVZKrlKZXaiBCQmip5qw3S9Y6hu8bSrOeXDI0cgcpbJKW0LWi6upqh75-gF6HTeSbMyWgrAW0StxTK-T6ux7NEc0uVJ8rUJLTlGLq7D8UP5YmZ3gtBsf6P4ZXd8U3_UT2z633k2dALYCJIaVIgzZu5uHwuCO6UQvQuyXTy5JpXjJ9u2R6y9bygXWf_qhJLqbEsF9RvO_GI67fiPflgw
CitedBy_id crossref_primary_10_1007_s11101_024_10044_y
crossref_primary_10_1016_j_jsbmb_2025_106674
crossref_primary_10_1186_s12903_024_05276_5
Cites_doi 10.1007/s00784-023-05122-y
10.1034/j.1600-0714.2000.290306.x
10.4081/ejh.2015.2451
10.1111/jre.12635
10.4103/0972-124X.134563
10.1136/bmj.n71
10.1016/j.cden.2019.08.002
10.1007/s12105-022-01482-1
10.4103/jomfp.jomfp_76_23
10.30476/dentjods.2023.95946.1909
10.1177/1721727X0500300303
10.7759/cureus.14597
10.3390/ijms20030707
10.1016/j.prp.2011.12.016
10.1007/s12105-023-01525-1
10.1016/j.archoralbio.2012.06.002
10.2147/JIR.S366620
10.1111/iep.12411
10.1182/blood-2015-07-660092
10.1186/s12885-018-5239-z
10.1016/j.oooo.2019.12.017
10.1016/j.jobcr.2017.05.001
10.1016/j.jcms.2021.02.027
10.3892/ijo.2014.2427
10.1111/j.1600-0714.2009.00853.x
10.1016/j.archoralbio.2017.12.017
10.21608/adjg.2017.5280
10.1111/jop.12524
10.34172/joddd.2021.012
10.1615/critrevimmunol.2015012327
10.5005/jp-journals-10024-3483
10.1002/cre2.293
10.1080/15592294.2015.1006506
10.1007/s00292-022-01150-9
10.1111/j.1600-0714.2009.00818.x
10.1016/j.anndiagpath.2017.08.002
10.3390/ijms242015264
10.14670/HH-25.541
10.1182/blood-2007-11-124693
10.1007/s40368-023-00800-7
10.1111/jop.12203
10.1007/s12105-023-01561-x
10.1111/cas.15199
10.18632/oncotarget.16311
10.1016/j.ijom.2022.02.005
10.4103/njms.njms_90_22
10.1186/s13287-020-01999-8
10.1002/cre2.516
10.1038/s41598-021-88676-9
10.2334/josnusd.54.165
10.1111/jop.12710
10.3389/fimmu.2021.807600
10.1038/s41418-020-0559-3
10.1111/j.1601-0825.2012.01924.x
10.7759/cureus.27734
10.3390/genes14091735
10.1111/j.1600-0714.2009.00851.x
10.2334/josnusd.53.67
10.4103/jomfp.jomfp_58_22
10.1016/j.oraloncology.2019.07.011
10.5146/tjpath.2022.01573
10.7150/ijbs.6662
10.1242/jcs.03218
10.1016/j.jobcr.2016.07.001
10.1016/j.archoralbio.2023
10.3892/ol.2013.1764
10.1186/1471-2407-7-108
10.1007/s10654-010-9491-z
10.4103/IJDS.IJDS_143_20
10.1111/odi.12646
10.1111/jop.12475
10.3390/ijms23168987
10.1186/1472-6831-14-150
10.1097/PAI.0000000000000785
10.1016/j.yexcr.2009.02.021
10.1186/s12935-023-02939-1
10.1007/s12105-021-01404-7
10.4103/jfmpc.jfmpc_1092_19
10.1006/bbrc.1998.8516
10.1007/s11033-021-06286-0
10.3390/ijms241411771
10.1055/a-2160-0368
10.4103/jomfp.jomfp_18_22
10.5005/jp-journals-10024-2194
10.1002/hed.21256
10.1002/9780470712184
10.3892/ol.2017.5905
10.1016/j.oraloncology.2019.104529
10.7759/cureus.38467
10.1111/febs.13968
10.1016/j.gene.2020.145369
10.1038/s41598-019-50652-9
10.1007/s12032-010-9668-z
10.1038/s41419-023-05755-7
10.3389/fgene.2023.1151651
10.1016/j.ejca.2019.08.028
10.3389/fphar.2022.964973
ContentType Journal Article
Copyright The Author(s) 2024
2024. The Author(s).
COPYRIGHT 2024 BioMed Central Ltd.
2024. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2024
– notice: 2024. The Author(s).
– notice: COPYRIGHT 2024 BioMed Central Ltd.
– notice: 2024. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FR3
FYUFA
GHDGH
K9.
M0S
M1P
M7Z
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOA
DOI 10.1186/s13000-024-01540-y
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Biochemistry Abstracts 1
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Biochemistry Abstracts 1
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

Publicly Available Content Database

MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: C6C
  name: SpringerOpen Free (Free internet resource, activated by CARLI)
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1746-1596
EndPage 22
ExternalDocumentID oai_doaj_org_article_f688e25e137943fca2cb88feeaea07e5
A808371488
39182093
10_1186_s13000_024_01540_y
Genre Meta-Analysis
Systematic Review
Journal Article
GroupedDBID ---
0R~
29G
2WC
53G
5GY
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
ABDBF
ABUWG
ACGFS
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M~E
O5R
O5S
OK1
OVT
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
WOQ
WOW
~8M
AAYXX
ALIPV
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7XB
8FD
8FK
AZQEC
DWQXO
FR3
K9.
M7Z
P64
PKEHL
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c552t-dadb18b0738663055afca970c85c0dd7e40a6d3ca13dbf0fc31ec74089118e3
IEDL.DBID DOA
ISSN 1746-1596
IngestDate Wed Aug 27 01:31:40 EDT 2025
Fri Sep 05 14:25:24 EDT 2025
Sat Jul 26 02:04:53 EDT 2025
Tue Jun 17 22:04:01 EDT 2025
Tue Jun 10 21:02:34 EDT 2025
Thu Apr 03 06:57:14 EDT 2025
Tue Jul 01 04:29:42 EDT 2025
Thu Apr 24 23:10:22 EDT 2025
Sat Sep 06 07:27:29 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Human
Odontogenic Tumors
PDPN Protein
Systematic Review
Odontogenic Cysts
Language English
License 2024. The Author(s).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c552t-dadb18b0738663055afca970c85c0dd7e40a6d3ca13dbf0fc31ec74089118e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
ORCID 0000-0002-4992-0567
0000-0001-8329-3205
0000-0001-6727-7969
OpenAccessLink https://doaj.org/article/f688e25e137943fca2cb88feeaea07e5
PMID 39182093
PQID 3102510781
PQPubID 54778
PageCount 22
ParticipantIDs doaj_primary_oai_doaj_org_article_f688e25e137943fca2cb88feeaea07e5
proquest_miscellaneous_3097149545
proquest_journals_3102510781
gale_infotracmisc_A808371488
gale_infotracacademiconefile_A808371488
pubmed_primary_39182093
crossref_citationtrail_10_1186_s13000_024_01540_y
crossref_primary_10_1186_s13000_024_01540_y
springer_journals_10_1186_s13000_024_01540_y
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-08-24
PublicationDateYYYYMMDD 2024-08-24
PublicationDate_xml – month: 08
  year: 2024
  text: 2024-08-24
  day: 24
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Diagnostic pathology
PublicationTitleAbbrev Diagn Pathol
PublicationTitleAlternate Diagn Pathol
PublicationYear 2024
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References F Aldahash (1540_CR19) 2023; 27
KC Tjioe (1540_CR51) 2012; 18
1540_CR62
M Marrelli (1540_CR75) 2013; 9
R Perumal (1540_CR81) 2014; 18
1540_CR63
M Black (1540_CR78) 2020; 101
K Umeizudike (1540_CR15) 2022; 8
M Tsuneki (1540_CR50) 2012; 208
OA Effiom (1540_CR11) 2018; 24
S Ghafouri-Fard (1540_CR14) 2021; 771
S Caetano Ados (1540_CR48) 2013; 58
C Lecerf (1540_CR82) 2019; 121
GG Malaguez (1540_CR33) 2020; 28
Y Nakazawa (1540_CR92) 2008; 112
N Singhal (1540_CR37) 2017; 7
1540_CR59
J Zhang (1540_CR77) 2011; 28
D Mohapatra (1540_CR61) 2023; 24
S Karinen (1540_CR70) 2022; 113
X Zhang (1540_CR49) 2014; 7
YF Li (1540_CR73) 2015; 10
A Tejchman (1540_CR90) 2017; 8
FF Duarte-Andrade (1540_CR16) 2020; 129
KR Magliocca (1540_CR6) 2023; 17
C Sánchez-Romero (1540_CR42) 2017; 46
DJ Schneider (1540_CR69) 2023
VC Bastos (1540_CR4) 2023; 17
CH Siar (1540_CR45) 2015; 44
N Vigneswaran (1540_CR100) 2007; 7
AC McLean (1540_CR13) 2023; 17
S Gupta (1540_CR17) 2023; 27
S Bommanavar (1540_CR102) 2023; 24
Z Zhang (1540_CR26) 2022; 15
1540_CR83
S Ghai (1540_CR12) 2022; 14
G Melo (1540_CR8) 2023; 24
D Pore (1540_CR101) 2015; 35
Z Wang (1540_CR67) 2021; 11
V Srinivasan (1540_CR104) 2023; 15
M Soluk-Tekkesin (1540_CR1) 2022; 38
Y Shin (1540_CR88) 1998; 245
T Naruse (1540_CR38) 2017; 13
E Okamoto (1540_CR55) 2010; 39
BO Hwang (1540_CR91) 2021; 12
X Yang (1540_CR105) 2020; 101
1540_CR71
Y Wang (1540_CR25) 2022; 13
A Stang (1540_CR60) 2010; 25
QH Xie (1540_CR79) 2023; 151
B Anjum (1540_CR29) 2023; 27
M Quintanilla (1540_CR22) 2019; 20
J Sikorska (1540_CR86) 2019; 19
M Alaeddini (1540_CR44) 2017; 46
KI Tosios (1540_CR87) 2000; 29
1540_CR23
Y Yang (1540_CR68) 2023; 14
1540_CR20
LN Cueni (1540_CR89) 2009; 315
E Martín-Villar (1540_CR93) 2006; 119
D Habba (1540_CR40) 2017; 4
P González-Alva (1540_CR54) 2011; 53
FN Bartuli (1540_CR28) 2012; 5
KA Kechik (1540_CR35) 2018; 32
K Kikuchi (1540_CR52) 2012; 54
S Gupta (1540_CR39) 2017; 18
1540_CR10
D Siegmund (1540_CR97) 2017; 284
1540_CR96
R Singh (1540_CR34) 2020; 9
S Saussez (1540_CR85) 2010; 25
A Chahar (1540_CR32) 2021; 13
R Mora-Molina (1540_CR98) 2022; 23
RE Friedrich (1540_CR53) 2012; 32
SM Ganvir (1540_CR41) 2016; 6
FN Bushabu (1540_CR5) 2023; 14
YF Costa (1540_CR46) 2015; 59
ZT Liang (1540_CR74) 2023; 14
RE Friedrich (1540_CR43) 2016; 36
C Rizzardi (1540_CR64) 2009; 29
S Etemad-Moghadam (1540_CR36) 2018; 47
M Noi (1540_CR103) 2020; 6
K Chutipongpisit (1540_CR72) 2021; 102
MJ Page (1540_CR58) 2021; 29
J Zustin (1540_CR56) 2010; 39
1540_CR2
PJW Stoelinga (1540_CR9) 2022; 51
A Farshbaf (1540_CR18) 2021; 48
EM Kalogirou (1540_CR3) 2023; 14
DT Oliveira (1540_CR47) 2014; 14
C Paddock (1540_CR94) 2016; 127
YM Feng (1540_CR95) 2016; 20
Q Wang (1540_CR80) 2021; 49
AB Rajendra Santosh (1540_CR7) 2020; 64
Q Jing (1540_CR66) 2023; 23
P González-Alva (1540_CR57) 2010; 39
Y Yu (1540_CR76) 2020; 11
PGP Gonçalves (1540_CR27) 2019; 54
AK Nayar (1540_CR31) 2022; 5
R Zolfaghari (1540_CR30) 2023; 1
J Gonzalez (1540_CR21) 2023; 24
N Onak Kandemir (1540_CR24) 2019; 9
D Stöhr (1540_CR99) 2020; 27
CW Lin (1540_CR84) 2014; 45
PN Antonio (1540_CR65) 2018; 87
References_xml – ident: 1540_CR71
  doi: 10.1007/s00784-023-05122-y
– volume: 29
  start-page: 139
  issue: 3
  year: 2000
  ident: 1540_CR87
  publication-title: J Oral Pathol Med.
  doi: 10.1034/j.1600-0714.2000.290306.x
– volume: 59
  start-page: 2451
  issue: 1
  year: 2015
  ident: 1540_CR46
  publication-title: Eur J Histochem.
  doi: 10.4081/ejh.2015.2451
– volume: 54
  start-page: 349
  issue: 4
  year: 2019
  ident: 1540_CR27
  publication-title: J Periodontal Res.
  doi: 10.1111/jre.12635
– volume: 18
  start-page: 293
  issue: 3
  year: 2014
  ident: 1540_CR81
  publication-title: J Indian Soc Periodontol.
  doi: 10.4103/0972-124X.134563
– volume: 29
  issue: 372
  year: 2021
  ident: 1540_CR58
  publication-title: BMJ.
  doi: 10.1136/bmj.n71
– volume: 64
  start-page: 105
  issue: 1
  year: 2020
  ident: 1540_CR7
  publication-title: Dent Clin North Am.
  doi: 10.1016/j.cden.2019.08.002
– volume: 17
  start-page: 275
  issue: 1
  year: 2023
  ident: 1540_CR4
  publication-title: Head Neck Pathol.
  doi: 10.1007/s12105-022-01482-1
– volume: 27
  start-page: 259
  issue: 2
  year: 2023
  ident: 1540_CR29
  publication-title: J Oral Maxillofac Pathol.
  doi: 10.4103/jomfp.jomfp_76_23
– volume: 1
  start-page: 1
  issue: 1
  year: 2023
  ident: 1540_CR30
  publication-title: J Dent Shiraz Univ Med Sci.
  doi: 10.30476/dentjods.2023.95946.1909
– volume: 29
  start-page: 1137
  issue: 4
  year: 2009
  ident: 1540_CR64
  publication-title: Anticancer Res.
– ident: 1540_CR63
  doi: 10.1177/1721727X0500300303
– ident: 1540_CR83
  doi: 10.7759/cureus.14597
– volume: 20
  start-page: 707
  issue: 3
  year: 2019
  ident: 1540_CR22
  publication-title: Int J Mol Sci.
  doi: 10.3390/ijms20030707
– volume: 208
  start-page: 140
  issue: 3
  year: 2012
  ident: 1540_CR50
  publication-title: Pathol Res Pract.
  doi: 10.1016/j.prp.2011.12.016
– volume: 17
  start-page: 85
  issue: 1
  year: 2023
  ident: 1540_CR13
  publication-title: Head Neck Pathol.
  doi: 10.1007/s12105-023-01525-1
– volume: 58
  start-page: 408
  issue: 4
  year: 2013
  ident: 1540_CR48
  publication-title: Arch Oral Biol.
  doi: 10.1016/j.archoralbio.2012.06.002
– volume: 15
  start-page: 3561
  year: 2022
  ident: 1540_CR26
  publication-title: J Inflamm Res.
  doi: 10.2147/JIR.S366620
– volume: 102
  start-page: 268
  issue: 6
  year: 2021
  ident: 1540_CR72
  publication-title: Int J Exp Pathol.
  doi: 10.1111/iep.12411
– volume: 127
  start-page: 1052
  issue: 8
  year: 2016
  ident: 1540_CR94
  publication-title: Blood.
  doi: 10.1182/blood-2015-07-660092
– volume: 19
  start-page: 85
  issue: 1
  year: 2019
  ident: 1540_CR86
  publication-title: BMC Cancer.
  doi: 10.1186/s12885-018-5239-z
– volume: 129
  start-page: 357
  issue: 4
  year: 2020
  ident: 1540_CR16
  publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol.
  doi: 10.1016/j.oooo.2019.12.017
– volume: 7
  start-page: 95
  issue: 2
  year: 2017
  ident: 1540_CR37
  publication-title: J Oral Biol Craniofac Res.
  doi: 10.1016/j.jobcr.2017.05.001
– volume: 49
  start-page: 562
  issue: 7
  year: 2021
  ident: 1540_CR80
  publication-title: J Craniomaxillofac Surg.
  doi: 10.1016/j.jcms.2021.02.027
– volume: 45
  start-page: 710
  issue: 2
  year: 2014
  ident: 1540_CR84
  publication-title: Int J Oncol.
  doi: 10.3892/ijo.2014.2427
– volume: 39
  start-page: 115
  issue: 1
  year: 2010
  ident: 1540_CR56
  publication-title: J Oral Pathol Med.
  doi: 10.1111/j.1600-0714.2009.00853.x
– volume: 87
  start-page: 151
  year: 2018
  ident: 1540_CR65
  publication-title: Arch Oral Biol.
  doi: 10.1016/j.archoralbio.2017.12.017
– volume: 4
  start-page: 331
  issue: 4
  year: 2017
  ident: 1540_CR40
  publication-title: Al-Azhar Dental Journal for Girls.
  doi: 10.21608/adjg.2017.5280
– volume: 46
  start-page: 618
  issue: 8
  year: 2017
  ident: 1540_CR42
  publication-title: J Oral Pathol Med.
  doi: 10.1111/jop.12524
– ident: 1540_CR20
  doi: 10.34172/joddd.2021.012
– volume: 35
  start-page: 15
  issue: 1
  year: 2015
  ident: 1540_CR101
  publication-title: Crit Rev Immunol.
  doi: 10.1615/critrevimmunol.2015012327
– volume: 24
  start-page: 195
  issue: 3
  year: 2023
  ident: 1540_CR102
  publication-title: J Contemp Dent Pract.
  doi: 10.5005/jp-journals-10024-3483
– volume: 6
  start-page: 420
  issue: 4
  year: 2020
  ident: 1540_CR103
  publication-title: Clin Exp Dent Res.
  doi: 10.1002/cre2.293
– volume: 10
  start-page: 229
  issue: 3
  year: 2015
  ident: 1540_CR73
  publication-title: Epigenetics.
  doi: 10.1080/15592294.2015.1006506
– ident: 1540_CR10
  doi: 10.1007/s00292-022-01150-9
– volume: 39
  start-page: 103
  issue: 1
  year: 2010
  ident: 1540_CR57
  publication-title: J Oral Pathol Med.
  doi: 10.1111/j.1600-0714.2009.00818.x
– volume: 32
  start-page: 17
  year: 2018
  ident: 1540_CR35
  publication-title: Ann Diagn Pathol.
  doi: 10.1016/j.anndiagpath.2017.08.002
– volume: 24
  start-page: 15264
  issue: 20
  year: 2023
  ident: 1540_CR21
  publication-title: Int J Mol Sci.
  doi: 10.3390/ijms242015264
– volume: 25
  start-page: 541
  issue: 5
  year: 2010
  ident: 1540_CR85
  publication-title: Histol Histopathol.
  doi: 10.14670/HH-25.541
– volume: 112
  start-page: 1730
  issue: 5
  year: 2008
  ident: 1540_CR92
  publication-title: Blood.
  doi: 10.1182/blood-2007-11-124693
– volume: 36
  start-page: 3103
  issue: 6
  year: 2016
  ident: 1540_CR43
  publication-title: Anticancer Res.
– volume: 24
  start-page: 451
  issue: 4
  year: 2023
  ident: 1540_CR8
  publication-title: Eur Arch Paediatr Dent.
  doi: 10.1007/s40368-023-00800-7
– volume: 44
  start-page: 51
  issue: 1
  year: 2015
  ident: 1540_CR45
  publication-title: J Oral Pathol Med.
  doi: 10.1111/jop.12203
– volume: 17
  start-page: 313
  issue: 2
  year: 2023
  ident: 1540_CR6
  publication-title: Head Neck Pathol.
  doi: 10.1007/s12105-023-01561-x
– volume: 113
  start-page: 17
  issue: 1
  year: 2022
  ident: 1540_CR70
  publication-title: Cancer Sci.
  doi: 10.1111/cas.15199
– volume: 20
  start-page: 4082
  issue: 19
  year: 2016
  ident: 1540_CR95
  publication-title: Eur Rev Med Pharmacol Sci.
– volume: 8
  start-page: 31876
  year: 2017
  ident: 1540_CR90
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.16311
– volume: 51
  start-page: 1420
  issue: 11
  year: 2022
  ident: 1540_CR9
  publication-title: Int J Oral Maxillofac Surg.
  doi: 10.1016/j.ijom.2022.02.005
– volume: 14
  start-page: 177
  issue: 2
  year: 2023
  ident: 1540_CR5
  publication-title: Natl J Maxillofac Surg.
  doi: 10.4103/njms.njms_90_22
– volume: 11
  start-page: 476
  issue: 1
  year: 2020
  ident: 1540_CR76
  publication-title: Stem Cell Res Ther.
  doi: 10.1186/s13287-020-01999-8
– volume: 8
  start-page: 359
  issue: 1
  year: 2022
  ident: 1540_CR15
  publication-title: Clin Exp Dent Res.
  doi: 10.1002/cre2.516
– volume: 11
  start-page: 9164
  issue: 1
  year: 2021
  ident: 1540_CR67
  publication-title: Sci Rep.
  doi: 10.1038/s41598-021-88676-9
– volume: 54
  start-page: 165
  issue: 2
  year: 2012
  ident: 1540_CR52
  publication-title: J Oral Sci.
  doi: 10.2334/josnusd.54.165
– volume: 47
  start-page: 519
  issue: 5
  year: 2018
  ident: 1540_CR36
  publication-title: J Oral Pathol Med.
  doi: 10.1111/jop.12710
– volume: 12
  year: 2021
  ident: 1540_CR91
  publication-title: Front Immunol.
  doi: 10.3389/fimmu.2021.807600
– volume: 27
  start-page: 3037
  issue: 11
  year: 2020
  ident: 1540_CR99
  publication-title: Cell Death Differ.
  doi: 10.1038/s41418-020-0559-3
– volume: 18
  start-page: 673
  issue: 7
  year: 2012
  ident: 1540_CR51
  publication-title: Oral Dis.
  doi: 10.1111/j.1601-0825.2012.01924.x
– volume: 32
  start-page: 2125
  issue: 5
  year: 2012
  ident: 1540_CR53
  publication-title: Anticancer Res.
– volume: 14
  issue: 8
  year: 2022
  ident: 1540_CR12
  publication-title: Cureus.
  doi: 10.7759/cureus.27734
– volume: 14
  start-page: 1735
  issue: 9
  year: 2023
  ident: 1540_CR3
  publication-title: Genes (Basel).
  doi: 10.3390/genes14091735
– volume: 39
  start-page: 110
  issue: 1
  year: 2010
  ident: 1540_CR55
  publication-title: J Oral Pathol Med.
  doi: 10.1111/j.1600-0714.2009.00851.x
– volume: 53
  start-page: 67
  issue: 1
  year: 2011
  ident: 1540_CR54
  publication-title: J Oral Sci.
  doi: 10.2334/josnusd.53.67
– volume: 27
  start-page: 168
  issue: 1
  year: 2023
  ident: 1540_CR19
  publication-title: J Oral Maxillofac Pathol.
  doi: 10.4103/jomfp.jomfp_58_22
– volume: 101
  year: 2020
  ident: 1540_CR105
  publication-title: Oral Oncol.
  doi: 10.1016/j.oraloncology.2019.07.011
– volume: 38
  start-page: 168
  issue: 2
  year: 2022
  ident: 1540_CR1
  publication-title: Turk Patoloji Derg.
  doi: 10.5146/tjpath.2022.01573
– volume: 9
  start-page: 1070
  issue: 10
  year: 2013
  ident: 1540_CR75
  publication-title: Int J Biol Sci.
  doi: 10.7150/ijbs.6662
– volume: 119
  start-page: 4541
  issue: Pt 21
  year: 2006
  ident: 1540_CR93
  publication-title: J Cell Sci.
  doi: 10.1242/jcs.03218
– volume: 6
  start-page: 187
  issue: 3
  year: 2016
  ident: 1540_CR41
  publication-title: J Oral Biol Craniofac Res.
  doi: 10.1016/j.jobcr.2016.07.001
– volume: 151
  year: 2023
  ident: 1540_CR79
  publication-title: VEGF-C. Arch Oral Biol.
  doi: 10.1016/j.archoralbio.2023
– volume: 7
  start-page: 627
  issue: 3
  year: 2014
  ident: 1540_CR49
  publication-title: Oncol Lett.
  doi: 10.3892/ol.2013.1764
– volume: 7
  start-page: 108
  year: 2007
  ident: 1540_CR100
  publication-title: BMC Cancer.
  doi: 10.1186/1471-2407-7-108
– volume: 25
  start-page: 603
  year: 2010
  ident: 1540_CR60
  publication-title: Eur. J. Epidemiol.
  doi: 10.1007/s10654-010-9491-z
– volume: 13
  start-page: 224
  issue: 4
  year: 2021
  ident: 1540_CR32
  publication-title: Indian Journal of Dental Sciences.
  doi: 10.4103/IJDS.IJDS_143_20
– volume: 24
  start-page: 307
  issue: 3
  year: 2018
  ident: 1540_CR11
  publication-title: Oral Dis.
  doi: 10.1111/odi.12646
– volume: 46
  start-page: 76
  issue: 1
  year: 2017
  ident: 1540_CR44
  publication-title: J Oral Pathol Med.
  doi: 10.1111/jop.12475
– volume: 23
  start-page: 8987
  issue: 16
  year: 2022
  ident: 1540_CR98
  publication-title: Int J Mol Sci.
  doi: 10.3390/ijms23168987
– volume: 14
  start-page: 150
  year: 2014
  ident: 1540_CR47
  publication-title: BMC Oral Health.
  doi: 10.1186/1472-6831-14-150
– volume: 28
  start-page: 513
  issue: 7
  year: 2020
  ident: 1540_CR33
  publication-title: Appl Immunohistochem Mol Morphol.
  doi: 10.1097/PAI.0000000000000785
– volume: 315
  start-page: 1715
  issue: 10
  year: 2009
  ident: 1540_CR89
  publication-title: Exp Cell Res.
  doi: 10.1016/j.yexcr.2009.02.021
– volume: 23
  start-page: 113
  issue: 1
  year: 2023
  ident: 1540_CR66
  publication-title: Cancer Cell Int.
  doi: 10.1186/s12935-023-02939-1
– volume: 5
  start-page: 441
  issue: S1
  year: 2022
  ident: 1540_CR31
  publication-title: International Journal of Health Sciences.
– ident: 1540_CR2
  doi: 10.1007/s12105-021-01404-7
– volume: 9
  start-page: 804
  issue: 2
  year: 2020
  ident: 1540_CR34
  publication-title: J Family Med Prim Care.
  doi: 10.4103/jfmpc.jfmpc_1092_19
– volume: 245
  start-page: 741
  issue: 3
  year: 1998
  ident: 1540_CR88
  publication-title: Biochem Biophys Res Commun.
  doi: 10.1006/bbrc.1998.8516
– volume: 48
  start-page: 3617
  issue: 4
  year: 2021
  ident: 1540_CR18
  publication-title: Mol Biol Rep.
  doi: 10.1007/s11033-021-06286-0
– volume: 24
  start-page: 11771
  issue: 14
  year: 2023
  ident: 1540_CR61
  publication-title: Int J Mol Sci.
  doi: 10.3390/ijms241411771
– year: 2023
  ident: 1540_CR69
  publication-title: Thromb Haemost.
  doi: 10.1055/a-2160-0368
– volume: 27
  start-page: 181
  issue: 1
  year: 2023
  ident: 1540_CR17
  publication-title: J Oral Maxillofac Pathol.
  doi: 10.4103/jomfp.jomfp_18_22
– ident: 1540_CR23
– volume: 18
  start-page: 1173
  issue: 12
  year: 2017
  ident: 1540_CR39
  publication-title: J Contemp Dent Pract.
  doi: 10.5005/jp-journals-10024-2194
– ident: 1540_CR96
  doi: 10.1002/hed.21256
– ident: 1540_CR59
  doi: 10.1002/9780470712184
– volume: 13
  start-page: 3487
  issue: 5
  year: 2017
  ident: 1540_CR38
  publication-title: Oncol Lett.
  doi: 10.3892/ol.2017.5905
– volume: 101
  year: 2020
  ident: 1540_CR78
  publication-title: Oral Oncol.
  doi: 10.1016/j.oraloncology.2019.104529
– volume: 15
  issue: 5
  year: 2023
  ident: 1540_CR104
  publication-title: Cureus.
  doi: 10.7759/cureus.38467
– volume: 5
  start-page: 33
  issue: 2–3
  year: 2012
  ident: 1540_CR28
  publication-title: Oral Implantol (Rome).
– volume: 284
  start-page: 1131
  issue: 8
  year: 2017
  ident: 1540_CR97
  publication-title: FEBS J.
  doi: 10.1111/febs.13968
– volume: 771
  year: 2021
  ident: 1540_CR14
  publication-title: Gene.
  doi: 10.1016/j.gene.2020.145369
– volume: 9
  start-page: 14230
  issue: 1
  year: 2019
  ident: 1540_CR24
  publication-title: Sci Rep.
  doi: 10.1038/s41598-019-50652-9
– volume: 28
  start-page: S626
  issue: Suppl 1
  year: 2011
  ident: 1540_CR77
  publication-title: Med Oncol.
  doi: 10.1007/s12032-010-9668-z
– ident: 1540_CR62
– volume: 14
  start-page: 257
  issue: 4
  year: 2023
  ident: 1540_CR68
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-023-05755-7
– volume: 14
  start-page: 1151651
  year: 2023
  ident: 1540_CR74
  publication-title: Front Genet.
  doi: 10.3389/fgene.2023.1151651
– volume: 121
  start-page: 210
  year: 2019
  ident: 1540_CR82
  publication-title: Eur J Cancer.
  doi: 10.1016/j.ejca.2019.08.028
– volume: 13
  year: 2022
  ident: 1540_CR25
  publication-title: Front Pharmacol.
  doi: 10.3389/fphar.2022.964973
SSID ssj0045520
Score 2.3600936
SecondaryResourceType review_article
Snippet Background Podoplanin (PDPN) is a transmembrane glycoprotein implicated in the pathogenesis of odontogenic lesions (OL). It is localized at the membrane and...
Podoplanin (PDPN) is a transmembrane glycoprotein implicated in the pathogenesis of odontogenic lesions (OL). It is localized at the membrane and cytoplasmic...
Background Podoplanin (PDPN) is a transmembrane glycoprotein implicated in the pathogenesis of odontogenic lesions (OL). It is localized at the membrane and...
BackgroundPodoplanin (PDPN) is a transmembrane glycoprotein implicated in the pathogenesis of odontogenic lesions (OL). It is localized at the membrane and...
Abstract Background Podoplanin (PDPN) is a transmembrane glycoprotein implicated in the pathogenesis of odontogenic lesions (OL). It is localized at the...
SourceID doaj
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 115
SubjectTerms Amino acids
Analysis
Biomarkers
CD31 antigen
Cell migration
Cell proliferation
Computational Biology - methods
Cysts
Diagnostic systems
Follicles
Glycoproteins
Human
Humans
Immunohistochemistry
Lesions
Maxillofacial surgery
Medical research
Medicine
Medicine & Public Health
Membrane Glycoproteins - analysis
Membrane Glycoproteins - metabolism
Meta-analysis
Odontogenic Cysts
Odontogenic Cysts - metabolism
Odontogenic Cysts - pathology
Odontogenic Tumors
Odontogenic Tumors - metabolism
Odontogenic Tumors - pathology
Pathogenesis
Pathology
Pattern analysis
PDPN Protein
Protein interaction
Protein Interaction Maps
Protein-protein interactions
Proteins
Reviews
Search strategies
Systematic Review
Tumors
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96vvgiJ35VT4kg-OCGS9ukTX2RUzwOQRFU2LeQJlNZWNv1tgd3D_7vzrRp11W812RSksxkPprMbxh70UCRK1MFYbyUQrnMC9M4ECoNGXidqUZScvLHT8XZN_VhqZfxh9s2PqucdOKgqEPn6R_5MbohaIoJmubN5qegqlF0uxpLaNxktwboMpTncjkHXErrTE6JMqY43tLVjRRolQR5DlJc7RmjAbP_X838h2n66650MEGnh-xO9B35ycjsu-wGtPfYr88YWG7Wrl21fEXJHh1cxset2NBy7G37DsVk5fkaqHX7mju-Q3DmY_bKgv-A3gkXQUoW3LWBz2ASgderLoKs0piJ7D77cvr-67szEWsqCI-70YvgQp2aWlKtz4LQvlzjXVVKb7SXIZSgpCtC7l2ah7qRjc9T8KWSBpWigfwBO2i7Fh4xntUlVLVuSgoppQejHOgyg1LXWeV1lbB02lrrI9w4Vb1Y2yHsMIUd2WGRHXZgh71K2Kt5zGYE27iW-i1xbKYkoOyhoTv_buO5s01hDGQa0pyQ8HCtma-NaQAcOFmCTthL4relHcTpeRezEnCRBIxlTwz6qCXGjCZhR3uUeAz9fvckMTaqga3dCW3Cns_dNJKetrXQXSANoXhhmKpwLg9HSZuXlFeEr1_lCVtMorf7-P935vH1c3nCbmfDIUAdqY7YQX9-AU_RterrZ8P5-Q1vVSJM
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Ni9UwEA-6gngRv-26SgTBgy-YpkmbelsXl0VYEVTYW0iTKTx42y6-LriH_d-dadO3-_wCr8mkNPORmWEyvzD2qoWy0LaOwgYphfYqCNt6EDqPCoJRupXUnHz8qTz6pj-emJMEk0O9MNfr97kt366p3CIFehJB3l6Ki5vslsmLcizMlgfzqauNUXJuivnjui3HM-Lz_34KX3NDv9RFR3dzeI_dTXEi358Ee5_dgO4Bu32cKuEP2eVnzCfPVr5bdnxJPR49_Eh3WnGg4zjbDT1qxzLwFdDo-h33_Aq4mU9NKwt-CoMXPmGTLLjvIt9gSETeLPuErUprZrJH7Mvhh68HRyI9pSACMmYQ0ccmt42kJz5LAvnybfB1JYM1QcZYgZa-jEXweRGbVrahyCFUWlo8Cy0Uj9lO13fwlHHVVFA3pq0ok5QBrPZgKgWVaVQdTJ2xfOayCwllnB67WLkx27ClmyTjUDJulIy7yNibzZqzCWPjn9TvSXgbSsLHHgdQbVwyN9eW1oIykBcEgId7VaGxtgXw4GUFJmOvSfSOOIi_F3xqRsBNEh6W27cYmlaYKtqM7W1RovWF7elZeVyy_rXDkBnDRoJRytjLzTStpBttHfTnSEPgXZidavyXJ5PSbbZU1ASrXxcZW8xaePXxv3Nm9__In7E7arQPPCr1HtsZvp_Dc4ywhubFaFo_AWdxHts
  priority: 102
  providerName: Springer Nature
Title Podoplanin immunoexpression in odontogenic lesions: a systematic review, meta-analysis, and integrated bioinformatic analysis
URI https://link.springer.com/article/10.1186/s13000-024-01540-y
https://www.ncbi.nlm.nih.gov/pubmed/39182093
https://www.proquest.com/docview/3102510781
https://www.proquest.com/docview/3097149545
https://doaj.org/article/f688e25e137943fca2cb88feeaea07e5
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3daxQxEA9aX3wRxa_VekQQfPBCs7vJJuvb9WgpB5ZiFe4tZLOzcHDdLd4W2of-787sx7WnqC8-LUwmSzIzmcyQzC-MfaggS5XNS2GDlEL5JAhbeRAqLhMIOlGVpOLkL6fZyXe1WOrlvae-6E5YDw_cC-6gyqyFREOcEpRZFfBvhbUVgAcvDXTopTKXYzLV-2CldSLHEhmbHWzo0EYK3I8ExQxS3OxsQx1a_-8--d6m9Mspabf5HD9lT4aokc_60T5jD6B-zm7PMKW8XPt6VfMVlXk0cD1ca0VCzbG1bhs0kFXgayDq5jP3_A67mfd1K1N-Aa0XfoAnmXJfl3wLI1HyYtUM8KrUZ2R7wc6Pj77NT8TwmoIIKI1WlL4sYltIeuUzI5wvj8LMjQxWB1mWBpT0WZkGH6dlUckqpDEEo6RFd2ghfcn26qaG14wnhYG80JWhZFIGsMqDNgkYXSR50HnE4lG0LgxA4_Texdp1CYfNXK8Oh-pwnTrcTcQ-bftc9jAbf-U-JI1tOQkiuyOg4bjBcNy_DCdiH0nfjiSIwwt-qEfASRIklptZjE4NZos2Yvs7nLgAw27zaDFucAAbh1EzRo6EpBSx99tm6kmX2mporpCH8LswQVU4lle9pW2nlOaErJ-nEZuOpnf38z9L5s3_kMxb9jjplgr6ULXP9tofV_AOQ6-2mLCHZmkm7NFstjhf4Pfw6PTsK1Ln2XzSrcCfdO4xKA
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Nb9MwFLdGd4ALAvEVGGAkEAdmzXGcxEFCaINNHduqCYa00yzHeUGVSlLWTtAD_xF_JO-lSUtB7Larv-T4fcd-v8fY8xKSSJusEMZLKbRTXpjSgdBhocDHSpeSkpOPBkn_s_5wGp-usV9dLgw9q-x0YqOoi9rTP_ItdEPQFBM0zdvxN0FVo-h2tSuhMWeLA5h9x5Bt8mb_PdL3hVJ7uyfv-qKtKiB8HKupKFyRhyaXVO0yIbwrV3qXpdKb2MuiSEFLlxSRd2FU5KUsfRSCT7U0qBYMRLjqNbauKZ-1x9Z3dgfHHzvNr3F92SXmmGRrQldFUqAVFOSpSDFbMX5NjYB_LcEfpvCvu9nG5O3dYjdbX5Vvz5nrNluD6g77eYyB7HjkqmHFh5RcUsOP9jEtNlQce6tpjWw59HwE1Dp5zR1fIkbzebbMJv8KUydcC4qyyV1V8AV4RcHzYd2CutKcbthd9ukKTvse61V1BQ8YV3kKWR6XKYWw0oPRDuJUQRrnKvNxFrCwO1rrW3hzqrIxsk2YYxI7J4dFctiGHHYWsFeLOeM5uMelo3eIYouRBMzdNNTnX2wr57ZMjAEVQxgR8h5-q_K5MSWAAydTiAP2kuht6QRxe961WRD4kQTEZbcN-sQpxqgmYBsrI1Hs_Wp3xzG2VTsTuxSSgD1bdNNMekpXQX2BYwg1DMNijXu5P-e0xSdFGeH5Z1HANjvWWy7-_5N5ePlenrLr_ZOjQ3u4Pzh4xG6oRiBQP-sN1pueX8BjdOum-ZNWmjg7u1rx_Q1l9mAl
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSBUXxJtAASMhcWCtOomdONxKYVUerSoBUm-WY0_QSkuy6qYSPfDfmcmrXV4SV3scxTOel8bzmbHnFWSpMkUQxksplEu8MJUDoeKQgNeJqiQ1Jx8eZQdf1PsTfXKpi7-77T6WJPueBkJpqtvdVah6FTfZ7pqKMFKgfxEUA0hxfpVdU-T6qFyb7Y-2WGmdyLFV5o_rNtxRh9r_u22-5Jx-qZZ2Tmh-k90Yoke-14v7FrsC9W22fTjUx--wH8eYZa6Wrl7UfEGdHw18H2664kDNcbZuGzwzC8-XQKPrV9zxCzhn3reyzPg3aJ1wA2LJjLs68AlZIvBy0QyIq7RmJLvLPs3fft4_EMMDC8IjY1oRXChjU0p6-DMj6C9XeVfk0hvtZQg5KOmykHoXp6GsZOXTGHyupEELaSC9x7bqpoYHjCdlDkWpq5zyS-nBKAc6TyDXZVJ4XUQsHrls_YA9Tk9gLG2Xg5jM9pKxKBnbScaeR-zltGbVI2_8k_o1CW-iJNTsbqA5_WoHJbRVZgwkGuKUYPFwr4kvjakAHDiZg47YCxK9JQ7i73k3tCjgJgkly-4ZDFhzTCBNxHY2KFEn_eb0eHjsYBPWFgNpDCYJXCliz6ZpWkn33GpozpCGIL0wZ1X4L_f7QzdtKS0IbL9IIzYbT-HFx__OmYf_R_6UbR-_mduP744-PGLXk05V0JaqHbbVnp7BYwzB2vJJp2U_AZu6Kg8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Podoplanin+immunoexpression+in+odontogenic+lesions%3A+a+systematic+review%2C+meta-analysis%2C+and+integrated+bioinformatic+analysis&rft.jtitle=Diagnostic+pathology&rft.au=Mario+Alberto+Alarc%C3%B3n-S%C3%A1nchez&rft.au=Getsemani+Luna-Bonilla&rft.au=Selenne+Romero-Servin&rft.au=Artak+Heboyan&rft.date=2024-08-24&rft.pub=BMC&rft.eissn=1746-1596&rft.volume=19&rft.issue=1&rft.spage=1&rft.epage=22&rft_id=info:doi/10.1186%2Fs13000-024-01540-y&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_f688e25e137943fca2cb88feeaea07e5
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1746-1596&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1746-1596&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1746-1596&client=summon